ZS Pharma, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (35)

View All

Latest Posts

About This Stock More About This Stock
AstraZeneca To Buy ZS Pharma For $2.7 Billion
Article By: Terry Chrisomalis
Friday, November 6, 2015 9:45 AM EDT
Today AstraZeneca (AZN) announced that it will acquire ZS Pharma (ZSPH) for $2.7 billion. According to the deal, AZN will acquire ZSPH for $90 per share in an all cash transaction.
In this article: ZSPH, AZN
Read
ZS Pharma - Chart Of The Day
Article By: Jim Van Meerten
Monday, February 23, 2015 8:52 PM EDT
ZSPH is focused on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. Since the Trend Spotter signaled a buy the stock gained 10.15%.
In this article: ZSPH
Read
All Posts

Latest Tweets for $ZSPH

No tweets yet!

PARTNER HEADLINES